Sign up to save your podcasts
Or
Share ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
This week’s episode will be focusing on an update of a late-breaking abstract presented at ASH 2025 this past week: the Phase 3 BRUIN-CLL 313 trial looking at Pirtobrutinib vs Bendamustine/Rituximab in 1L Chronic Lymphocytic Leukemia (CLL).
View all episodes
By Sam and Karine
4.8
189189 ratings
This week’s episode will be focusing on an update of a late-breaking abstract presented at ASH 2025 this past week: the Phase 3 BRUIN-CLL 313 trial looking at Pirtobrutinib vs Bendamustine/Rituximab in 1L Chronic Lymphocytic Leukemia (CLL).
More shows like Two Onc Docs
View all
NEJM This Week
317 Listeners
JAMA Clinical Reviews
497 Listeners
Research To Practice | Oncology Videos
120 Listeners
ASCO Daily News
58 Listeners
Mayo Clinic Talks
297 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
45 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Run the List
248 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
44 Listeners